1. Home
  2. VIGL vs AOUT Comparison

VIGL vs AOUT Comparison

Compare VIGL & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • AOUT
  • Stock Information
  • Founded
  • VIGL 2020
  • AOUT 2020
  • Country
  • VIGL United States
  • AOUT United States
  • Employees
  • VIGL N/A
  • AOUT N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • AOUT Ordnance And Accessories
  • Sector
  • VIGL Health Care
  • AOUT Industrials
  • Exchange
  • VIGL Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • VIGL 95.2M
  • AOUT 188.4M
  • IPO Year
  • VIGL 2022
  • AOUT N/A
  • Fundamental
  • Price
  • VIGL $1.70
  • AOUT $15.15
  • Analyst Decision
  • VIGL Buy
  • AOUT Strong Buy
  • Analyst Count
  • VIGL 6
  • AOUT 2
  • Target Price
  • VIGL $16.60
  • AOUT $12.50
  • AVG Volume (30 Days)
  • VIGL 387.1K
  • AOUT 111.8K
  • Earning Date
  • VIGL 11-07-2024
  • AOUT 12-05-2024
  • Dividend Yield
  • VIGL N/A
  • AOUT N/A
  • EPS Growth
  • VIGL N/A
  • AOUT N/A
  • EPS
  • VIGL N/A
  • AOUT N/A
  • Revenue
  • VIGL N/A
  • AOUT $201,598,000.00
  • Revenue This Year
  • VIGL N/A
  • AOUT $5.63
  • Revenue Next Year
  • VIGL N/A
  • AOUT $6.85
  • P/E Ratio
  • VIGL N/A
  • AOUT N/A
  • Revenue Growth
  • VIGL N/A
  • AOUT 3.66
  • 52 Week Low
  • VIGL $1.60
  • AOUT $7.45
  • 52 Week High
  • VIGL $6.06
  • AOUT $16.00
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 23.30
  • AOUT 82.15
  • Support Level
  • VIGL $1.60
  • AOUT $14.39
  • Resistance Level
  • VIGL $2.46
  • AOUT $16.00
  • Average True Range (ATR)
  • VIGL 0.16
  • AOUT 0.82
  • MACD
  • VIGL -0.02
  • AOUT 0.18
  • Stochastic Oscillator
  • VIGL 11.63
  • AOUT 84.81

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: